Envestnet Asset Management Inc. Sells 70,268 Shares of Option Care Health, Inc. (NASDAQ:OPCH)

Envestnet Asset Management Inc. reduced its stake in Option Care Health, Inc. (NASDAQ:OPCH - Free Report) by 30.5% in the 4th quarter, according to the company in its most recent filing with the SEC. The fund owned 160,331 shares of the company's stock after selling 70,268 shares during the quarter. Envestnet Asset Management Inc. owned approximately 0.09% of Option Care Health worth $3,719,000 at the end of the most recent reporting period.

Other institutional investors have also made changes to their positions in the company. Wells Fargo & Company MN raised its holdings in shares of Option Care Health by 9.5% in the 4th quarter. Wells Fargo & Company MN now owns 180,391 shares of the company's stock worth $4,185,000 after buying an additional 15,609 shares in the last quarter. Landscape Capital Management L.L.C. grew its holdings in Option Care Health by 102.3% during the 4th quarter. Landscape Capital Management L.L.C. now owns 29,775 shares of the company's stock worth $691,000 after acquiring an additional 15,055 shares during the period. ExodusPoint Capital Management LP increased its stake in shares of Option Care Health by 167.8% in the 4th quarter. ExodusPoint Capital Management LP now owns 54,810 shares of the company's stock valued at $1,272,000 after acquiring an additional 34,340 shares during the last quarter. Trexquant Investment LP acquired a new stake in Option Care Health during the 4th quarter worth $10,161,000. Finally, Headlands Technologies LLC acquired a new position in Option Care Health in the 4th quarter worth $359,000. 98.05% of the stock is currently owned by institutional investors.

Insider Transactions at Option Care Health

In other Option Care Health news, insider Michael Bavaro sold 30,996 shares of the business's stock in a transaction on Friday, February 28th. The shares were sold at an average price of $33.26, for a total value of $1,030,926.96. Following the sale, the insider now owns 44,974 shares in the company, valued at $1,495,835.24. The trade was a 40.80 % decrease in their position. The sale was disclosed in a document filed with the Securities & Exchange Commission, which is available through the SEC website. Company insiders own 0.64% of the company's stock.

Option Care Health Trading Up 5.3 %

NASDAQ:OPCH traded up $1.62 during midday trading on Wednesday, reaching $32.31. 4,194,293 shares of the stock traded hands, compared to its average volume of 1,809,966. The company has a debt-to-equity ratio of 0.77, a quick ratio of 1.32 and a current ratio of 1.73. Option Care Health, Inc. has a 12 month low of $21.39 and a 12 month high of $35.53. The stock has a market capitalization of $5.31 billion, a P/E ratio of 27.15, a PEG ratio of 2.30 and a beta of 1.07. The company has a fifty day moving average of $33.34 and a 200 day moving average of $28.82.

Option Care Health (NASDAQ:OPCH - Get Free Report) last announced its earnings results on Tuesday, April 29th. The company reported $0.40 EPS for the quarter, beating analysts' consensus estimates of $0.36 by $0.04. The firm had revenue of $1.33 billion for the quarter, compared to analysts' expectations of $1.26 billion. Option Care Health had a net margin of 4.37% and a return on equity of 15.30%. The company's quarterly revenue was up 16.3% on a year-over-year basis. During the same quarter in the previous year, the business posted $0.26 EPS. On average, research analysts predict that Option Care Health, Inc. will post 1.22 EPS for the current year.

Wall Street Analyst Weigh In

OPCH has been the topic of several research analyst reports. UBS Group upgraded Option Care Health from a "neutral" rating to a "buy" rating and upped their price objective for the company from $38.00 to $40.00 in a research note on Wednesday. Bank of America raised shares of Option Care Health from a "neutral" rating to a "buy" rating and boosted their target price for the stock from $26.00 to $33.00 in a report on Monday, January 13th. JPMorgan Chase & Co. upped their target price on Option Care Health from $40.00 to $41.00 and gave the company an "overweight" rating in a report on Thursday, March 6th. JMP Securities reissued a "market outperform" rating and issued a $36.00 price objective on shares of Option Care Health in a research report on Tuesday, April 22nd. Finally, Barrington Research reaffirmed an "outperform" rating and issued a $38.00 price target on shares of Option Care Health in a research note on Wednesday. One investment analyst has rated the stock with a hold rating and seven have assigned a buy rating to the company's stock. According to MarketBeat, the company presently has an average rating of "Moderate Buy" and a consensus price target of $35.50.

Option Care Health Company Profile

Option Care Health, Inc offers home and alternate site infusion services in the United States. The company provides anti-infective therapies; home infusion services to treat heart failures; home parenteral nutrition and enteral nutrition support services for numerous acute and chronic conditions, such as stroke, cancer, and gastrointestinal diseases; immunoglobulin infusion therapies for the treatment of immune deficiencies; and treatments for chronic inflammatory disorders, including crohn's disease, plaque psoriasis, psoriatic arthritis, rheumatoid arthritis, ulcerative colitis, and other chronic inflammatory disorders.